DUAL GLP-1/GIP MEDICATION

Tirzepatide

The same active ingredient as Mounjaro® and Zepbound® — dual-action weight loss.

$259/month

What is Tirzepatide?

Tirzepatide is a groundbreaking medication that targets two key hormones involved in appetite and blood sugar regulation: GLP-1 and GIP. This dual-action approach makes it one of the most effective weight loss medications ever developed.

Originally developed for type 2 diabetes under the brand name Mounjaro®, tirzepatide was later approved for weight loss as Zepbound®. Clinical trials showed unprecedented results, with many patients losing 20% or more of their body weight.

Our compounded Tirzepatide contains the same active ingredient as brand-name medications, prepared by licensed 503A compounding pharmacies at a significantly lower cost.

Why Dual-Action is Better

Unlike single-hormone medications, Tirzepatide targets both GLP-1 and GIP receptors for enhanced results.

1️⃣

GLP-1 Action

  • • Reduces appetite
  • • Slows gastric emptying
  • • Regulates blood sugar
  • • Signals fullness to the brain
2️⃣

GIP Action

  • • Enhances insulin sensitivity
  • • Improves fat metabolism
  • • Reduces fat storage
  • • Amplifies GLP-1 effects

Together = More effective weight loss than GLP-1 alone

Clinical Results

20-25%

Average Body Weight Loss

In the SURMOUNT trials, participants lost an average of 20-25% of their body weight.

91%

Lost 5% or More

91% of participants achieved clinically meaningful weight loss of 5% or more.

*Based on SURMOUNT clinical trial results at highest dose. Individual results may vary.

Semaglutide vs Tirzepatide

FeatureSemaglutideTirzepatide
MechanismGLP-1 onlyGLP-1 + GIP
Avg Weight Loss15-20%20-25%
Injection FrequencyWeeklyWeekly
Price$179/mo$259/mo
Time to Results4-8 weeks4-8 weeks

Both are highly effective. Your provider will help you choose the best option.

Dosing Schedule

Tirzepatide is gradually increased to minimize side effects and find your optimal dose.

MonthWeekly DosePurpose
Month 12.5mgInitiation - body adjustment
Month 25.0mgFirst escalation
Month 37.5mgContinued titration
Month 410mgIncreased efficacy
Month 512.5mgNear maximum
Month 6+15mgMaximum dose

Many patients see excellent results at lower doses. Your provider will customize your plan.

Possible Side Effects

Common (usually temporary)

  • Nausea
  • Diarrhea
  • Constipation
  • Decreased appetite
  • Vomiting
  • Abdominal pain

GI side effects typically improve within 4-8 weeks as your body adjusts.

Rare but serious

  • Pancreatitis
  • Gallbladder problems
  • Hypoglycemia (when combined with insulin)
  • Allergic reactions
  • Thyroid tumors (in animal studies)

Contact your provider immediately if you experience severe symptoms.

Compare & Save

Mounjaro®

$1,000+

/month

Zepbound®

$1,000+

/month

GetSlimRX

$259

/month

Save up to 75%

Ready to Start Tirzepatide?

Take our 2-minute quiz to see if you qualify.

Take the Quiz →